479 related articles for article (PubMed ID: 25656366)
1. Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes.
Gorin Y; Cavaglieri RC; Khazim K; Lee DY; Bruno F; Thakur S; Fanti P; Szyndralewiez C; Barnes JL; Block K; Abboud HE
Am J Physiol Renal Physiol; 2015 Jun; 308(11):F1276-87. PubMed ID: 25656366
[TBL] [Abstract][Full Text] [Related]
2. Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.
Jha JC; Gray SP; Barit D; Okabe J; El-Osta A; Namikoshi T; Thallas-Bonke V; Wingler K; Szyndralewiez C; Heitz F; Touyz RM; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
J Am Soc Nephrol; 2014 Jun; 25(6):1237-54. PubMed ID: 24511132
[TBL] [Abstract][Full Text] [Related]
3. Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease.
Gray SP; Jha JC; Kennedy K; van Bommel E; Chew P; Szyndralewiez C; Touyz RM; Schmidt HHHW; Cooper ME; Jandeleit-Dahm KAM
Diabetologia; 2017 May; 60(5):927-937. PubMed ID: 28160092
[TBL] [Abstract][Full Text] [Related]
4. APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury.
Cha JJ; Min HS; Kim KT; Kim JE; Ghee JY; Kim HW; Lee JE; Han JY; Lee G; Ha HJ; Bae YS; Lee SR; Moon SH; Lee SC; Kim G; Kang YS; Cha DR
Lab Invest; 2017 Apr; 97(4):419-431. PubMed ID: 28165467
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.
Aoyama T; Paik YH; Watanabe S; Laleu B; Gaggini F; Fioraso-Cartier L; Molango S; Heitz F; Merlot C; Szyndralewiez C; Page P; Brenner DA
Hepatology; 2012 Dec; 56(6):2316-27. PubMed ID: 22806357
[TBL] [Abstract][Full Text] [Related]
6. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo.
Jiang JX; Chen X; Serizawa N; Szyndralewiez C; Page P; Schröder K; Brandes RP; Devaraj S; Török NJ
Free Radic Biol Med; 2012 Jul; 53(2):289-96. PubMed ID: 22618020
[TBL] [Abstract][Full Text] [Related]
7. Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy.
Sedeek M; Callera G; Montezano A; Gutsol A; Heitz F; Szyndralewiez C; Page P; Kennedy CR; Burns KD; Touyz RM; Hébert RL
Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1348-58. PubMed ID: 20630933
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation.
Lan T; Kisseleva T; Brenner DA
PLoS One; 2015; 10(7):e0129743. PubMed ID: 26222337
[TBL] [Abstract][Full Text] [Related]
9. mTORC2 Signaling Regulates Nox4-Induced Podocyte Depletion in Diabetes.
Eid S; Boutary S; Braych K; Sabra R; Massaad C; Hamdy A; Rashid A; Moodad S; Block K; Gorin Y; Abboud HE; Eid AA
Antioxid Redox Signal; 2016 Nov; 25(13):703-719. PubMed ID: 27393154
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of NOX1/4 with GKT137831: a potential novel treatment to attenuate neuroglial cell inflammation in the retina.
Deliyanti D; Wilkinson-Berka JL
J Neuroinflammation; 2015 Jul; 12():136. PubMed ID: 26219952
[TBL] [Abstract][Full Text] [Related]
11. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases.
Eid AA; Gorin Y; Fagg BM; Maalouf R; Barnes JL; Block K; Abboud HE
Diabetes; 2009 May; 58(5):1201-11. PubMed ID: 19208908
[TBL] [Abstract][Full Text] [Related]
13. Mammalian target of rapamycin regulates Nox4-mediated podocyte depletion in diabetic renal injury.
Eid AA; Ford BM; Bhandary B; de Cassia Cavaglieri R; Block K; Barnes JL; Gorin Y; Choudhury GG; Abboud HE
Diabetes; 2013 Aug; 62(8):2935-47. PubMed ID: 23557706
[TBL] [Abstract][Full Text] [Related]
14. Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney.
Gorin Y; Block K; Hernandez J; Bhandari B; Wagner B; Barnes JL; Abboud HE
J Biol Chem; 2005 Nov; 280(47):39616-26. PubMed ID: 16135519
[TBL] [Abstract][Full Text] [Related]
15. A pan-NADPH Oxidase Inhibitor Ameliorates Kidney Injury in Type 1 Diabetic Rats.
Dorotea D; Kwon G; Lee JH; Saunders E; Bae YS; Moon SH; Lee SJ; Cha DR; Ha H
Pharmacology; 2018; 102(3-4):180-189. PubMed ID: 30099457
[TBL] [Abstract][Full Text] [Related]
16. The Nox1/4 Dual Inhibitor GKT137831 or Nox4 Knockdown Inhibits Angiotensin-II-Induced Adult Mouse Cardiac Fibroblast Proliferation and Migration. AT1 Physically Associates With Nox4.
Somanna NK; Valente AJ; Krenz M; Fay WP; Delafontaine P; Chandrasekar B
J Cell Physiol; 2016 May; 231(5):1130-41. PubMed ID: 26445208
[TBL] [Abstract][Full Text] [Related]
17. Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes.
Maalouf RM; Eid AA; Gorin YC; Block K; Escobar GP; Bailey S; Abboud HE
Am J Physiol Cell Physiol; 2012 Feb; 302(3):C597-604. PubMed ID: 22031600
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of NOX4 ameliorates alcohol-induced liver injury in mice through improving oxidative stress and mitochondrial function.
Sun Q; Zhang W; Zhong W; Sun X; Zhou Z
Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):2912-2921. PubMed ID: 27634671
[TBL] [Abstract][Full Text] [Related]
19. Salvianolate ameliorates oxidative stress and podocyte injury through modulation of NOX4 activity in db/db mice.
Liang Y; Liu H; Fang Y; Lin P; Lu Z; Zhang P; Jiao X; Teng J; Ding X; Dai Y
J Cell Mol Med; 2021 Jan; 25(2):1012-1023. PubMed ID: 33332718
[TBL] [Abstract][Full Text] [Related]
20. NADPH oxidase 1/4 inhibition attenuates the portal hypertensive syndrome via modulation of mesenteric angiogenesis and arterial hyporeactivity in rats.
Deng W; Duan M; Qian B; Zhu Y; Lin J; Zheng L; Zhang C; Qi X; Luo M
Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):255-265. PubMed ID: 30413372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
